1 / 22

Chapt. 9 Regulation of Enzymes

Chapt. 9 Regulation of Enzymes. Regulation of Enzymes Student Learning Outcomes : Explain that enzyme activities must be regulated for proper body function Explain three general mechanisms: Reversible binding in active site: substrate, inhibitors

edward
Download Presentation

Chapt. 9 Regulation of Enzymes

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Chapt. 9 Regulation of Enzymes • Regulation of Enzymes • Student Learning Outcomes: • Explain that enzyme activities must be regulated for proper body function • Explain three general mechanisms: • Reversible binding in active site: • substrate, inhibitors • Changing conformation of active site of enzyme: • Allosteric effectors, covalent modification, • Protein-protein interactions, zymogen cleavage • (Changing concentration of enzyme) • Synthesis, degradation

  2. Regulation of metabolic pathways • Metabolic pathway analogous to cars on highway: • Flux of substrates affected by rate-limiting enzyme (barrier) • Removal of barrier increases flow • Activating rate-limiting enzyme Fig. 9.1

  3. Regulation of glucose metabolism pathway • Ex. Regulation of glucose metabolism pathway: • Hexokinase & glucokinases convert glucose -> G-6-P in cells • Glycolysis for energy • Feedback regulation by ATP • Store G-6-P as glycogen • Feedforward by insulin

  4. II. Regulation by substrate, product concentration • Michaelis-Menten equation describes kinetics: • More substrate gives more reaction, to maximal • Vi (initial velocity) relates to concentration of substrate [S] to Vmax (maximal velocity) and Km ([S] for 1/2 Vmax • Applies to simple reactions: • E + S  ES  E + P; k1 = forward, k2 back; k3 for E+P • Vi = Vmax[S]/ Km + [S] Km = k2 + k3/k1; Vmax = k3[Et]

  5. II. Regulation by substrate, product concentration: • Ex.Graph of Michaelis-Menten equation has limit of Vmax at infinite substrate. • Km = [S] where Vmax/2 • Ex. Glucokinase Km 5 mM: • If blood glucose 4 mM -> • Vi = 0.44 Vmax • (Vm x 4mM/ (5mM + 4 mM) • Blood glucose 20 mM -> • Vi = 0.8 Vmax • (Vm x 20mM/ 5 + 20 mM Fig. 9.2

  6. Different isozymes have different Km for glucose • Different hexokinases differ in Km for glucose: • glucose + ATP -> G-6-P + ADP • Hexokinase I • (rbc) only glycolysis • Glucokinase • (liver, pancreas) storage • Fasting blood sugar • about 5 mM (90 mg/dL) so • rbc can function even if low • blood sugar of glucose • S0.5 = half-max for S-shape curve Fig. 9.3

  7. Reversible inhibitors decrease reaction velocity • Regulation through active site: reversible inhibitors • Competitive inhibitors compete with substrate Overcome by excess substrate (increase apparent Km) • Noncompetitive do not compete with substrate Not overcome by substrate (lowers [E] and Vmax) Products can also inhibit enzyme activity Fig. 9.4

  8. III. Regulation through conformational changes • Regulation through conformational changes of enzyme can affect catalytic site: • Allostery • – ex. Glycogen phosphorylase • Phosphorylation • – ex. Glycogen phosphorylase kinase • Protein-protein interactions • - ex. Protein kinase A • Proteolytic cleavage • - ex. chymotrypsinogen

  9. A. Allosteric Activators and inhibitors • Allosteric enzymes: • Often multimeric, • Exhibit positive cooperativity in substrate binding (ex. Hemoglobin and O2) • T (taut state) inactive without substrate • R (relaxed) state active with substrate Fig. 9.5

  10. Allosteric activators and inhibitors • Allosteric enzymes often cooperative S binding • Allosteric activators and inhibitors: • Bind at allosteric site, • not catalytic site • Conformational change • Activators often bind • R (relaxed) state • decrease S0.5 • Inhibitors often bind • T (taut state) • increase S0.5 Fig. 9.6

  11. B. Conformational change by covalent modification • Phosphorylation can activate or inhibit enzymes: • Protein kinases add phosphate • Protein phosphatases remove • PO42- adds bulky group, • negative charge, interacts • with other amino acids Fig. 9.7

  12. Muscle glycogen phosphorylase regulation • Muscle glycogen phosphorylase is regulated by both phosphorylation and/or allostery: • Rate-limiting step glycogen -> glucose-1-PO4 • ATP use increases AMP - allostery • phosphorylation increases activity • Signal from PKA Fig. 9.8

  13. Ex. Protein kinase A • Protein kinase A: Regulatory, catalytic subunits: • Ser/thr protein kinase, phosphorylates many enzymes • Including glycogen phosphorylase kinase • Adrenline increase cAMP, dissociates R subunits, • Starts PO4 cascade Fig. 9.9 cAMP activates PKA

  14. Other covalent modifications affect proteins • Covalent modifications affect protein activity, location in cell: • acetyl- (on histones) • ADP-ribosylation • (as by cholera toxin on Ga subunit) • Lipid addition (as on Ras protein) Fig. 6.13 modified amino acids

  15. Conformational changes from Protein-Protein interactions • Ca-Calmodulinfamily of modulator proteins • activated when [Ca2+ ] increases. • Ca2+/calmodulin binds to targets • e.g. protein kinases, allosteric result CaMkinasefamily activated by Ca2+/calmodulin; phosphorylate metabolic enzymes, ion channels, transcription factors, regulate synthesis, release of neurotransmitters. Fig. 9.10

  16. Small monomeric G proteins • Small (monomeric) G proteins • affect conformation of other proteins: • GTP bound form binds and activates or inhibits • GDP bound form inactive • Other intermediates regulate the G proteins (GEF, GAP, etc) • Ras family (Ras, Rho, Rab, Ran, Arf) • diverse roles in cells Fig. 9.11

  17. Proteolytic cleavage is irreversible • Proteolytic cleavage is irreversible conformational change: • Some during synthesis and processing • Others after secretion: • Proenzymes inactive: • Ex. Precursor protease is zymogen: • (chymotrypsinogen is cleaved by trypsin in intestine) • Ex. Blood clotting factors fibrinogen, prothrombin

  18. Regulation of pathways • Regulation of metabolic pathways is complex: • Sequential steps, different enzymes, rate-limiting one • Match regulation to function of path Fig. 9.12

  19. Lineweaver-Burk plot • Lineweaver-Burk transformation converts Michaelis-Menten to straight line (y = mx + b) • double reciprocal plot • Ease of determining • Km and Vmax Fig. 9.13

  20. Lineaver-Burk plots permit comparisons • Lineweaver-Burk plots permit analysis of enzyme kinetics, characterization of inhibitors Fig. 9.14

  21. Key concepts • Key concepts: • Enzyme activity is regulated to reflect physiological state • Rate of enzyme reaction depends on concentration of substrate, enzyme • Allosteric activators or inhibitors bind sites other than the active site: conformational • Mechanisms of regulation of enzyme activity include: feedback inhibition, covalent modifications, interactions of modulator proteins (rate synthesis, degradation)

  22. Review questions • 3. Methanol (CH3OH) is converted by alcohol dehydrogenases (ADH) to formaldehyde (CH2O), a highly toxic compound . Patients ingested toxic levels of methanol can be treated with ethanol (CH3CH2OH) to inhibit methanol oxidation by ADH. Which is the best rationale for this treatment? • Ethanol is structural analog of methanol – noncompetitive inhibitor • Ethanol is structural analog of methanol – will compete with methanol for binding enzyme • Ethanol will alter the Vmax of ADH for oxidation of methanol. • Ethanol is effective inhibitor of methanol oxidation regardless of the concentration of methanol • Ethanol will inhibit enzyme by binding the formadehyde-binding site on the enzyme, even though it cannot bind the substrate binding site for methanol.

More Related